The latest round of Medicare price cuts affect 15 drugs, including Xtandi, an older prostate cancer drug from Pfizer and Astellas Pharma Inc. that will face a 48% discount off its 2024 list price. GSK Plc’s asthma drug Trelegy Ellipta will face a 73% drop.

Health insurers are pulling out of the Medicare Advantage market. Discover which areas will gain or lose the most, and what to do if your plan is canceled.

The US government said Tuesday it negotiated a 71% discount off of the list price of Novo Nordisk A/S’s blockbuster drugs Ozempic and Wegovy for patients in Medicare, the federal health insurance program for the elderly.

Medicare officials have backed off a plan that would have clawed back $7.8 billion from hospitals a decade sooner than originally planned.

See New York’s top-rated Medicare Supplement Insurance companies, price comparisons and popular Medigap plan types. Many, or all, of the products featured on this page are from our advertising partners who compensate us when you take certain actions on ...